Additionally, AFP is still a relatively high sensitivity and specificity biomarker for surveillance and diagnosis for HBV‐HCC, AASLD standard of ALT may not be most appropriate for used in the Chinese population. The gene discussed is AFP; the disease is hepatocellular carcinoma.